E
Theralase Technologies Inc.
TLT.V
TSX
E
Sell
4/1/2025Downgrade
Theralase Technologies Inc. (TLT.V) was downgraded to E+ from D- on 4/1/2025 due to a decline in the total return index and volatility index.
Theralase Technologies Inc. (TLT.V) was downgraded to E+ from D- on 4/1/2025 due to a decline in the total return index and volatility index.
D
Sell
12/20/2024Upgraded
Theralase Technologies Inc. (TLT.V) was upgraded to D- from E+ on 12/20/2024 due to an increase in the volatility index, total return index and valuation index.
Theralase Technologies Inc. (TLT.V) was upgraded to D- from E+ on 12/20/2024 due to an increase in the volatility index, total return index and valuation index.
E
Sell
11/29/2024Downgrade
Theralase Technologies Inc. (TLT.V) was downgraded to E+ from D- on 11/29/2024 due to a decline in the volatility index.
Theralase Technologies Inc. (TLT.V) was downgraded to E+ from D- on 11/29/2024 due to a decline in the volatility index.
D
Sell
11/20/2024Upgraded
Theralase Technologies Inc. (TLT.V) was upgraded to D- from E+ on 11/20/2024 due to an increase in the total return index and volatility index.
Theralase Technologies Inc. (TLT.V) was upgraded to D- from E+ on 11/20/2024 due to an increase in the total return index and volatility index.
E
Sell
11/5/2024Downgrade
Theralase Technologies Inc. (TLT.V) was downgraded to E+ from D- on 11/5/2024 due to a decline in the volatility index, valuation index and growth index.
Theralase Technologies Inc. (TLT.V) was downgraded to E+ from D- on 11/5/2024 due to a decline in the volatility index, valuation index and growth index.
D
Sell
10/21/2024Upgraded
Theralase Technologies Inc. (TLT.V) was upgraded to D- from E+ on 10/21/2024 due to an increase in the solvency index and volatility index. The quick ratio increased from 0.67 to 0.67.
Theralase Technologies Inc. (TLT.V) was upgraded to D- from E+ on 10/21/2024 due to an increase in the solvency index and volatility index. The quick ratio increased from 0.67 to 0.67.
E
Sell
4/1/2024Downgrade
Theralase Technologies Inc. (TLT.V) was downgraded to E+ from D- on 4/1/2024 due to a noticeable decline in the solvency index and volatility index.
Theralase Technologies Inc. (TLT.V) was downgraded to E+ from D- on 4/1/2024 due to a noticeable decline in the solvency index and volatility index.
D
Sell
3/14/2024Upgraded
Theralase Technologies Inc. (TLT.V) was upgraded to D- from E+ on 3/14/2024 due to an increase in the growth index and volatility index. Operating cash flow increased 46.96% from -$835.6 to -$443.2, total revenue increased 28.34% from $163 to $209.2, and earnings per share increased from -$0.004 to -$0.0035.
Theralase Technologies Inc. (TLT.V) was upgraded to D- from E+ on 3/14/2024 due to an increase in the growth index and volatility index. Operating cash flow increased 46.96% from -$835.6 to -$443.2, total revenue increased 28.34% from $163 to $209.2, and earnings per share increased from -$0.004 to -$0.0035.
E
Sell
9/19/2023Downgrade
Theralase Technologies Inc. (TLT.V) was downgraded to E+ from D- on 9/19/2023 due to a major decline in the solvency index, total return index and volatility index.
Theralase Technologies Inc. (TLT.V) was downgraded to E+ from D- on 9/19/2023 due to a major decline in the solvency index, total return index and volatility index.
D
Sell
3/14/2023Downgrade
Theralase Technologies Inc. (TLT.V) was downgraded to D- from D on 3/14/2023 due to a noticeable decline in the total return index.
Theralase Technologies Inc. (TLT.V) was downgraded to D- from D on 3/14/2023 due to a noticeable decline in the total return index.
D
Sell
2/23/2023Upgraded
Theralase Technologies Inc. (TLT.V) was upgraded to D from D- on 02/23/2023.
Theralase Technologies Inc. (TLT.V) was upgraded to D from D- on 02/23/2023.
D
Sell
2/8/2023Downgrade
Theralase Technologies Inc. (TLT.V) was downgraded to D- from D on 2/8/2023 due to a decline in the growth index, solvency index and valuation index. Total revenue declined 25.21% from $267 to $199.7, EBIT declined 9.04% from -$976.7 to -$1.07M, and earnings per share declined from -$0.0048 to -$0.0052.
Theralase Technologies Inc. (TLT.V) was downgraded to D- from D on 2/8/2023 due to a decline in the growth index, solvency index and valuation index. Total revenue declined 25.21% from $267 to $199.7, EBIT declined 9.04% from -$976.7 to -$1.07M, and earnings per share declined from -$0.0048 to -$0.0052.
D
Sell
4/29/2022Upgraded
Theralase Technologies Inc. (TLT.V) was upgraded to D from D- on 4/29/2022 due to an increase in the valuation index.
Theralase Technologies Inc. (TLT.V) was upgraded to D from D- on 4/29/2022 due to an increase in the valuation index.
D
Sell
4/20/2022Downgrade
Theralase Technologies Inc. (TLT.V) was downgraded to D- from D on 4/20/2022 due to a decline in the valuation index and solvency index. The quick ratio declined from 7.14 to 6.34.
Theralase Technologies Inc. (TLT.V) was downgraded to D- from D on 4/20/2022 due to a decline in the valuation index and solvency index. The quick ratio declined from 7.14 to 6.34.
D
Sell
11/9/2021Upgraded
Theralase Technologies Inc. (TLT.V) was upgraded to D from E+ on 11/09/2021.
Theralase Technologies Inc. (TLT.V) was upgraded to D from E+ on 11/09/2021.
E
Sell
11/8/2021Downgrade
Theralase Technologies Inc. (TLT.V) was downgraded to E+ from D on 11/8/2021 due to a decline in the volatility index and valuation index.
Theralase Technologies Inc. (TLT.V) was downgraded to E+ from D on 11/8/2021 due to a decline in the volatility index and valuation index.
D
Sell
2/8/2021Upgraded
Theralase Technologies Inc. (TLT.V) was upgraded to D from D- on 2/8/2021 due to a noticeable increase in the growth index and volatility index. Operating cash flow increased 35.3% from -$921.9 to -$596.5, total revenue increased 33.82% from $131.3 to $175.7, and EBIT increased 8.36% from -$1.19M to -$1.09M.
Theralase Technologies Inc. (TLT.V) was upgraded to D from D- on 2/8/2021 due to a noticeable increase in the growth index and volatility index. Operating cash flow increased 35.3% from -$921.9 to -$596.5, total revenue increased 33.82% from $131.3 to $175.7, and EBIT increased 8.36% from -$1.19M to -$1.09M.
D
Sell
5/8/2020Downgrade
Theralase Technologies Inc. (TLT.V) was downgraded to D- from D on 5/8/2020 due to a significant decline in the efficiency index, valuation index and growth index. EBIT declined 69.29% from -$1.35M to -$2.29M, net income declined 68.79% from -$1.35M to -$2.28M, and earnings per share declined from -$0.0094 to -$0.0156.
Theralase Technologies Inc. (TLT.V) was downgraded to D- from D on 5/8/2020 due to a significant decline in the efficiency index, valuation index and growth index. EBIT declined 69.29% from -$1.35M to -$2.29M, net income declined 68.79% from -$1.35M to -$2.28M, and earnings per share declined from -$0.0094 to -$0.0156.
D
Sell
11/29/2019Upgraded
Theralase Technologies Inc. (TLT.V) was upgraded to D from D- on 11/29/2019 due to a significant increase in the efficiency index, solvency index and valuation index. The quick ratio increased from 1.59 to 18.27, total capital increased 508.42% from $2.08M to $12.67M, and debt to equity declined from 0.02 to 0.
Theralase Technologies Inc. (TLT.V) was upgraded to D from D- on 11/29/2019 due to a significant increase in the efficiency index, solvency index and valuation index. The quick ratio increased from 1.59 to 18.27, total capital increased 508.42% from $2.08M to $12.67M, and debt to equity declined from 0.02 to 0.
D
Sell
5/31/2019Downgrade
Theralase Technologies Inc. (TLT.V) was downgraded to D- from D on 5/31/2019 due to a large decline in the growth index, total return index and efficiency index. Operating cash flow declined 346.98% from -$432.7 to -$1.93M, total revenue declined 73.72% from $346.6 to $91.1, and net income declined 50% from -$564.2 to -$846.3.
Theralase Technologies Inc. (TLT.V) was downgraded to D- from D on 5/31/2019 due to a large decline in the growth index, total return index and efficiency index. Operating cash flow declined 346.98% from -$432.7 to -$1.93M, total revenue declined 73.72% from $346.6 to $91.1, and net income declined 50% from -$564.2 to -$846.3.
D
Sell
4/18/2019Upgraded
Theralase Technologies Inc. (TLT.V) was upgraded to D from D- on 4/18/2019 due to a noticeable increase in the total return index, efficiency index and solvency index. Total capital increased 69.85% from $430.9 to $731.9, and the quick ratio increased from 0.56 to 0.71.
Theralase Technologies Inc. (TLT.V) was upgraded to D from D- on 4/18/2019 due to a noticeable increase in the total return index, efficiency index and solvency index. Total capital increased 69.85% from $430.9 to $731.9, and the quick ratio increased from 0.56 to 0.71.
D
Sell
2/11/2019Upgraded
Theralase Technologies Inc. (TLT.V) was upgraded to D- from E+ on 2/11/2019 due to an increase in the total return index and volatility index.
Theralase Technologies Inc. (TLT.V) was upgraded to D- from E+ on 2/11/2019 due to an increase in the total return index and volatility index.
E
Sell
1/16/2019Downgrade
Theralase Technologies Inc. (TLT.V) was downgraded to E+ from D- on 1/16/2019 due to a significant decline in the solvency index, total return index and volatility index. The quick ratio declined from 0.62 to 0.56.
Theralase Technologies Inc. (TLT.V) was downgraded to E+ from D- on 1/16/2019 due to a significant decline in the solvency index, total return index and volatility index. The quick ratio declined from 0.62 to 0.56.
D
Sell
3/11/2016Downgrade
Theralase Technologies Inc. (TLT.V) was downgraded to D- from D on 3/11/2016 due to a noticeable decline in the volatility index, efficiency index and valuation index. Net income declined 37.84% from -$1.09M to -$1.51M, and total capital declined 26.31% from $6.71M to $4.94M.
Theralase Technologies Inc. (TLT.V) was downgraded to D- from D on 3/11/2016 due to a noticeable decline in the volatility index, efficiency index and valuation index. Net income declined 37.84% from -$1.09M to -$1.51M, and total capital declined 26.31% from $6.71M to $4.94M.
D
Sell
8/28/2015Downgrade
Theralase Technologies Inc. (TLT.V) was downgraded to D from D+ on 8/28/2015 due to a large decline in the volatility index, efficiency index and total return index. Total capital declined 12.41% from $7.66M to $6.71M.
Theralase Technologies Inc. (TLT.V) was downgraded to D from D+ on 8/28/2015 due to a large decline in the volatility index, efficiency index and total return index. Total capital declined 12.41% from $7.66M to $6.71M.
D
Sell
6/2/2015Upgraded
Theralase Technologies Inc. (TLT.V) was upgraded to D+ from D on 6/2/2015 due to a major increase in the efficiency index, volatility index and growth index. Total capital increased 168.21% from $2.85M to $7.66M, earnings per share increased from -$0.0079 to -$0.0092, and EBIT increased 3.3% from -$743.5 to -$768.
Theralase Technologies Inc. (TLT.V) was upgraded to D+ from D on 6/2/2015 due to a major increase in the efficiency index, volatility index and growth index. Total capital increased 168.21% from $2.85M to $7.66M, earnings per share increased from -$0.0079 to -$0.0092, and EBIT increased 3.3% from -$743.5 to -$768.
D
Sell
12/3/2014Upgraded
Theralase Technologies Inc. (TLT.V) was upgraded to D from D- on 12/3/2014 due to an increase in the valuation index, efficiency index and volatility index. Net income increased 203.66% from -$317 to -$962.6.
Theralase Technologies Inc. (TLT.V) was upgraded to D from D- on 12/3/2014 due to an increase in the valuation index, efficiency index and volatility index. Net income increased 203.66% from -$317 to -$962.6.
D
Sell
9/3/2014Downgrade
Theralase Technologies Inc. (TLT.V) was downgraded to D- from D+ on 9/3/2014 due to a major decline in the efficiency index, volatility index and valuation index.
Theralase Technologies Inc. (TLT.V) was downgraded to D- from D+ on 9/3/2014 due to a major decline in the efficiency index, volatility index and valuation index.
D
Sell
5/12/2014Downgrade
Theralase Technologies Inc. (TLT.V) was downgraded to D+ from C- on 5/12/2014 due to a large decline in the volatility index and total return index.
Theralase Technologies Inc. (TLT.V) was downgraded to D+ from C- on 5/12/2014 due to a large decline in the volatility index and total return index.
C
Hold
4/16/2014Upgraded
Theralase Technologies Inc. (TLT.V) was upgraded to C- from D+ on 4/16/2014 due to an increase in the volatility index and valuation index.
Theralase Technologies Inc. (TLT.V) was upgraded to C- from D+ on 4/16/2014 due to an increase in the volatility index and valuation index.
D
Sell
3/6/2014Downgrade
Theralase Technologies Inc. (TLT.V) was downgraded to D+ from C- on 3/6/2014 due to a decline in the total return index.
Theralase Technologies Inc. (TLT.V) was downgraded to D+ from C- on 3/6/2014 due to a decline in the total return index.
